IR
AMRI

Invictus RG’s Albany Molecular Research Inc AMRI Stock Holding History

Invictus RG’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,929
Closed -$324K – 806
2017
Q2 		$324K Buy
+14,929
New +$271K 0.24% 168

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Invictus RG's AMRI Position: Q3 2017 in Review

Invictus RG sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 14,929 shares — an estimated $324K sold.

Invictus RG first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $324K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Invictus RG reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Invictus RG sold 14,929 Albany Molecular Research Inc shares in Q3 2017, an estimated $324K.
  • Invictus RG first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Invictus RG's Albany Molecular Research Inc position peaked at $324K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Invictus RG's 13F filing for Q3 2017, filed 13 Nov 2017.